Tenofovir DF 300 mg + Lamivudine 300 mg + Efavirenz 600 mg
This fixed-dose antiretroviral combination is indicated for the treatment of HIV-1 infection. As recommended by WHO and NACO guidelines, it is used as a first-line antiretroviral therapy (ART) regimen to effectively suppress viral replication.
Product Details
Therapeutic Class
Nucleos(t)ide Reverse Transcriptase Inhibitors (Tenofovir DF + Lamivudine)
Non-Nucleoside Reverse Transcriptase Inhibitor (Efavirenz)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
One tablet once daily, preferably at bedtime, or as prescribed by a healthcare professional.
To be used strictly as part of an ART regimen in line with treatment guidelines.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 Tablets
Tenofovir DF 300 mg + Lamivudine 300 mg + Efavirenz 600 mg
This fixed-dose antiretroviral combination is indicated for the treatment of HIV-1 infection. As recommended by WHO and NACO guidelines, it is used as a first-line antiretroviral therapy (ART) regimen to effectively suppress viral replication.
Product Details
Therapeutic Class
Nucleos(t)ide Reverse Transcriptase Inhibitors (Tenofovir DF + Lamivudine)
Non-Nucleoside Reverse Transcriptase Inhibitor (Efavirenz)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
One tablet once daily, preferably at bedtime, or as prescribed by a healthcare professional.
To be used strictly as part of an ART regimen in line with treatment guidelines.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 Tablets
Tenofovir DF 300 mg + Lamivudine 300 mg + Efavirenz 600 mg
This fixed-dose antiretroviral combination is indicated for the treatment of HIV-1 infection. As recommended by WHO and NACO guidelines, it is used as a first-line antiretroviral therapy (ART) regimen to effectively suppress viral replication.
Product Details
Therapeutic Class
Nucleos(t)ide Reverse Transcriptase Inhibitors (Tenofovir DF + Lamivudine)
Non-Nucleoside Reverse Transcriptase Inhibitor (Efavirenz)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
One tablet once daily, preferably at bedtime, or as prescribed by a healthcare professional.
To be used strictly as part of an ART regimen in line with treatment guidelines.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 Tablets